Biodyne Co., Ltd. (KOSDAQ:314930)

Biodyne Statistics

Total Valuation

Biodyne has a market cap or net worth of KRW 414.91 billion. The enterprise value is 395.60 billion.

Market Cap	414.91B
Enterprise Value	395.60B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Biodyne has 29.76 million shares outstanding. The number of shares has increased by 10.52% in one year.

Current Share Class	29.76M
Shares Outstanding	29.76M
Shares Change (YoY)	+10.52%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	42.06%
Owned by Institutions (%)	0.48%
Float	17.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	73.55
PB Ratio	9.73
P/TBV Ratio	10.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-832.26
EV / Sales	70.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-277.70

Financial Position

The company has a current ratio of 52.20, with a Debt / Equity ratio of 0.00.

Current Ratio	52.20
Quick Ratio	50.72
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-9,179.76

Financial Efficiency

Return on equity (ROE) is -1.11% and return on invested capital (ROIC) is -2.19%.

Return on Equity (ROE)	-1.11%
Return on Assets (ROA)	-2.15%
Return on Invested Capital (ROIC)	-2.19%
Return on Capital Employed (ROCE)	-3.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	5.49

Taxes

Income Tax	-232.94M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.40% in the last 52 weeks. The beta is 1.72, so Biodyne's price volatility has been higher than the market average.

Beta (5Y)	1.72
52-Week Price Change	-1.40%
50-Day Moving Average	14,688.40
200-Day Moving Average	14,920.15
Relative Strength Index (RSI)	39.07
Average Volume (20 Days)	74,342

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biodyne had revenue of KRW 5.64 billion and -475.33 million in losses. Loss per share was -15.32.

Revenue	5.64B
Gross Profit	3.35B
Operating Income	-1.51B
Pretax Income	-708.28M
Net Income	-475.33M
EBITDA	-3.53M
EBIT	-1.51B
Loss Per Share	-15.32

Balance Sheet

The company has 19.32 billion in cash and 6.33 million in debt, giving a net cash position of 19.31 billion or 648.82 per share.

Cash & Cash Equivalents	19.32B
Total Debt	6.33M
Net Cash	19.31B
Net Cash Per Share	648.82
Equity (Book Value)	42.66B
Book Value Per Share	1,447.26
Working Capital	20.80B

Cash Flow

In the last 12 months, operating cash flow was -612.90 million and capital expenditures -811.68 million, giving a free cash flow of -1.42 billion.

Operating Cash Flow	-612.90M
Capital Expenditures	-811.68M
Free Cash Flow	-1.42B
FCF Per Share	-47.86

Margins

Gross margin is 59.38%, with operating and profit margins of -26.69% and -8.43%.

Gross Margin	59.38%
Operating Margin	-26.69%
Pretax Margin	-12.56%
Profit Margin	-8.43%
EBITDA Margin	-0.06%
EBIT Margin	-26.69%
FCF Margin	n/a

Dividends & Yields

Biodyne does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.52%
Shareholder Yield	n/a
Earnings Yield	-0.11%
FCF Yield	-0.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Feb 28, 2024
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	3